Patent Baristas

The Biotechnology Industry Organization (BIO) will take the wraps off some findings from a report on the role of Intellectual Property Rights (IPRs) in encouraging upstream R&D and downstream commercialization in biotechnology at the 2012 BIO International Convention in Boston. “Taking Stock: the Gains of Global Biotechnology Research from IPRs” The report, titled “Taking Stock: […]

With four days left until BIO 2012 in Boston, EvaluatePharma’s World Preview 2018 warns of excessive R&D spending, but patent cliff may “liberate” drug companies.  EvaluatePharma released a report on the pharmaceutical industry entitled “World Preview 2018: Embracing the Patent Cliff,” whcih includes analysts’ forecasts on which companies and products will come out as winners […]

The 2012 BIO International Convention will feature an educational track devoted to Biotech Patenting and Tech Transfer to discuss legal and legislative developments and how they are likely to impact biotech companies.   Hosted by the Biotechnology Industry Organization(BIO), this year’s global event for biotechnology will take place June 18-21, 2012 at the Boston Convention and […]

It’s day numbah five until BIO 2012 Convention hits beantown in a flurry of activity, Chris Christie, the Republican governor of New Jersey known for his combative style, was named the BIO 2012 Governor of the Year. The Award was presented to Governor Christie at a special ceremony at the State House in Trenton joined […]

“There are 10,000 baby boomers entering Medicare every day… If you could delay the onset of Alzheimer’s by five years, you’d save Medicare $50 billion a year. That’s what biotechnology companies do.”  ~Jim Greenwood James Greenwood, President & CEO of the Biotechnology Industry Organization (BIO) gave the keynote speech at the BioOhio conference yesterday outlining […]

The Biotechnology Industry Organization believes that fully realizing the promise of biotechnology requires a comprehensive national strategy that fine-tunes some policies and overhauls others. BIO’s set of policy proposals address two vital needs: 1) the need to re-engineer the biotech economic model, and 2) the need to re-invent the idea-to-market pathway for biotech cures and […]

The Biotechnology Industry Organization believes that fully realizing the promise of biotechnology requires a comprehensive national strategy that fine-tunes some policies and overhauls others. BIO’s set of policy proposals address two vital needs: 1) the need to re-engineer the biotech economic model, and 2) the need to re-invent the idea-to-market pathway for biotech cures and […]

When you’re networking with more than 15,000 of your closest friends at the BIO International Convention in Washington, DC, you’re bound to meet an interesting person or two.  I met more than that. At this year’s convention, I met either the most interesting person I’ve ever met or the craziest person I’ve ever met.  Or […]